Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)

Clinical trial NCT05601700 · RECRUITING

Trial details

NCT number: NCT05601700
Sponsor: Ente Ospedaliero Ospedali Galliera
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Ovarian Epithelial Low Grade Serous Adenocarcinoma of Ovary

Start date: 2022-09-22
Primary completion: 2029-09-22
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.